ENST00000711482.1:c.6127C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The ENST00000711482.1(CACNA1H):​c.6127C>T​(p.Arg2043Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0116 in 1,520,138 control chromosomes in the GnomAD database, including 136 homozygotes. In-silico tool predicts a benign outcome for this variant. 5/6 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R2043G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0087 ( 10 hom., cov: 35)
Exomes 𝑓: 0.012 ( 126 hom. )

Consequence

CACNA1H
ENST00000711482.1 missense

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -1.72

Publications

1 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 16-1220166-C-T is Benign according to our data. Variant chr16-1220166-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 96017.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00869 (1323/152330) while in subpopulation NFE AF = 0.014 (949/68010). AF 95% confidence interval is 0.0132. There are 10 homozygotes in GnomAd4. There are 576 alleles in the male GnomAd4 subpopulation. Median coverage is 35. This position passed quality control check.
BS2
High AC in GnomAd4 at 1323 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.6234C>T p.Cys2078Cys synonymous_variant Exon 35 of 35 ENST00000348261.11 NP_066921.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000711482.1 linkc.6127C>T p.Arg2043Cys missense_variant Exon 36 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.6076C>T p.Arg2026Cys missense_variant Exon 35 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.6049C>T p.Arg2017Cys missense_variant Exon 36 of 36 ENSP00000518768.1
CACNA1HENST00000348261.11 linkc.6234C>T p.Cys2078Cys synonymous_variant Exon 35 of 35 1 NM_021098.3 ENSP00000334198.7
CACNA1HENST00000569107.6 linkc.6249C>T p.Cys2083Cys synonymous_variant Exon 34 of 34 1 ENSP00000454990.2
CACNA1HENST00000711493.1 linkc.6219C>T p.Cys2073Cys synonymous_variant Exon 34 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.6216C>T p.Cys2072Cys synonymous_variant Exon 34 of 34 1 ENSP00000455840.1
CACNA1HENST00000711450.1 linkc.6216C>T p.Cys2072Cys synonymous_variant Exon 35 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.6201C>T p.Cys2067Cys synonymous_variant Exon 35 of 35 1 ENSP00000457555.2
CACNA1HENST00000638323.1 linkc.6195C>T p.Cys2065Cys synonymous_variant Exon 35 of 35 5 ENSP00000492267.1
CACNA1HENST00000562079.6 linkc.6183C>T p.Cys2061Cys synonymous_variant Exon 34 of 34 1 ENSP00000454581.2
CACNA1HENST00000711438.1 linkc.6177C>T p.Cys2059Cys synonymous_variant Exon 34 of 34 ENSP00000518754.1
CACNA1HENST00000637236.3 linkn.*2153C>T non_coding_transcript_exon_variant Exon 34 of 34 5 ENSP00000492650.2
CACNA1HENST00000639478.1 linkn.*1282C>T non_coding_transcript_exon_variant Exon 35 of 35 5 ENSP00000491945.1
CACNA1HENST00000640028.1 linkn.*4052C>T non_coding_transcript_exon_variant Exon 35 of 35 5 ENSP00000491488.1
CACNA1HENST00000711442.1 linkn.*5678C>T non_coding_transcript_exon_variant Exon 33 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.*1175C>T non_coding_transcript_exon_variant Exon 36 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.*1093C>T non_coding_transcript_exon_variant Exon 35 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.*1813C>T non_coding_transcript_exon_variant Exon 36 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.*901C>T non_coding_transcript_exon_variant Exon 36 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.*868C>T non_coding_transcript_exon_variant Exon 36 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.*148C>T non_coding_transcript_exon_variant Exon 34 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.6234C>T non_coding_transcript_exon_variant Exon 35 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.6201C>T non_coding_transcript_exon_variant Exon 35 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.*1350C>T non_coding_transcript_exon_variant Exon 35 of 35 ENSP00000518777.1
CACNA1HENST00000711483.1 linkc.*148C>T 3_prime_UTR_variant Exon 35 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.*148C>T 3_prime_UTR_variant Exon 34 of 34 ENSP00000518769.1
CACNA1HENST00000637236.3 linkn.*2153C>T 3_prime_UTR_variant Exon 34 of 34 5 ENSP00000492650.2
CACNA1HENST00000639478.1 linkn.*1282C>T 3_prime_UTR_variant Exon 35 of 35 5 ENSP00000491945.1
CACNA1HENST00000640028.1 linkn.*4052C>T 3_prime_UTR_variant Exon 35 of 35 5 ENSP00000491488.1
CACNA1HENST00000711442.1 linkn.*5678C>T 3_prime_UTR_variant Exon 33 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.*1175C>T 3_prime_UTR_variant Exon 36 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.*1093C>T 3_prime_UTR_variant Exon 35 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.*1813C>T 3_prime_UTR_variant Exon 36 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.*901C>T 3_prime_UTR_variant Exon 36 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.*868C>T 3_prime_UTR_variant Exon 36 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.*148C>T 3_prime_UTR_variant Exon 34 of 35 ENSP00000518773.1
CACNA1HENST00000711488.1 linkn.*1350C>T 3_prime_UTR_variant Exon 35 of 35 ENSP00000518777.1
CACNA1HENST00000621827.2 linkn.6121+113C>T intron_variant Intron 35 of 36 6 ENSP00000518766.1

Frequencies

GnomAD3 genomes
AF:
0.00869
AC:
1323
AN:
152212
Hom.:
10
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.00265
Gnomad AMI
AF:
0.0275
Gnomad AMR
AF:
0.00876
Gnomad ASJ
AF:
0.00980
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.00207
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0140
Gnomad OTH
AF:
0.0162
GnomAD2 exomes
AF:
0.00947
AC:
1528
AN:
161270
AF XY:
0.00939
show subpopulations
Gnomad AFR exome
AF:
0.00270
Gnomad AMR exome
AF:
0.0101
Gnomad ASJ exome
AF:
0.0125
Gnomad EAS exome
AF:
0.000422
Gnomad FIN exome
AF:
0.00221
Gnomad NFE exome
AF:
0.0142
Gnomad OTH exome
AF:
0.0115
GnomAD4 exome
AF:
0.0119
AC:
16236
AN:
1367808
Hom.:
126
Cov.:
72
AF XY:
0.0115
AC XY:
7738
AN XY:
673204
show subpopulations
African (AFR)
AF:
0.00160
AC:
45
AN:
28070
American (AMR)
AF:
0.00970
AC:
312
AN:
32162
Ashkenazi Jewish (ASJ)
AF:
0.0121
AC:
255
AN:
21028
East Asian (EAS)
AF:
0.000113
AC:
4
AN:
35528
South Asian (SAS)
AF:
0.00247
AC:
178
AN:
71974
European-Finnish (FIN)
AF:
0.00275
AC:
133
AN:
48282
Middle Eastern (MID)
AF:
0.0108
AC:
58
AN:
5362
European-Non Finnish (NFE)
AF:
0.0137
AC:
14677
AN:
1069114
Other (OTH)
AF:
0.0102
AC:
574
AN:
56288
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
978
1957
2935
3914
4892
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
546
1092
1638
2184
2730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00869
AC:
1323
AN:
152330
Hom.:
10
Cov.:
35
AF XY:
0.00773
AC XY:
576
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.00265
AC:
110
AN:
41584
American (AMR)
AF:
0.00875
AC:
134
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00980
AC:
34
AN:
3470
East Asian (EAS)
AF:
0.000387
AC:
2
AN:
5174
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4832
European-Finnish (FIN)
AF:
0.00207
AC:
22
AN:
10628
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.0140
AC:
949
AN:
68010
Other (OTH)
AF:
0.0161
AC:
34
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
68
136
203
271
339
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00780
Hom.:
16
Bravo
AF:
0.00889
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 25, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CACNA1H: BS1, BS2 -

not specified Benign:2
Jul 12, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 03, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
2.0
DANN
Benign
0.90
PhyloP100
-1.7
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs59844753; hg19: chr16-1270166; COSMIC: COSV52353423; COSMIC: COSV52353423; API